Myc Potentiates Apoptosis by Stimulating Bax Activity at the Mitochondria

REFERENCES

• Adachi, S., R. A. Gottlieb, and B. M. Babior. 1998. Lack of release of cytochrome C from mitochondria into cytosol early in the course of Fas-mediated apoptosis of Jurkat cells. J. Biol. Chem. 273:19892–19894.
   PubMedGoogle Scholar
• Adams, J. M., and S. Cory. 1998. The Bcl-2 protein family: arbiters of cell survival. Science 281:1322–1326.
   PubMed Web of Science ®Google Scholar
• Alarcon, R. M., B. A. Rupnow, T. G. Graeber, S. J. Knox, and A. J. Giaccia. 1996. Modulation of c-Myc activity and apoptosis in vivo. Cancer Res. 56:4315–4319.
   PubMed Web of Science ®Google Scholar
• Amati, B., K. Alevizopoulos, and J. Vlach. 1998. Myc and the cell cycle. Front. Biosci. 3:D250–D268.
   PubMed Web of Science ®Google Scholar
• Annis, M. G., et al. Oncogene, in press.
   Google Scholar
• Askew, D. S., R. A. Ashmun, B. C. Simmons, and J. L. Cleveland. 1991. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6:1915–1922.
   PubMed Web of Science ®Google Scholar
• Brenner, C., H. Cadiou, H. L. Vieira, N. Zamzami, I. Marzo, Z. Xie, B. Leber, D. Andrews, H. Duclohier, J. C. Reed, and G. Kroemer. 2000. Bcl-2 and Bax regulate the channel activity of the mitochondrial adenine nucleotide translocator. Oncogene 19:329–336.
   PubMed Web of Science ®Google Scholar
• Bush, A., M. Mateyak, K. Dugan, A. Obaya, S. Adachi, J. Sedivy, and M. Cole. 1998. c-myc null cells misregulate cad and gadd45 but not other proposed c-Myc targets. Genes Dev. 12:3797–3802.
   PubMed Web of Science ®Google Scholar
• Chang, D. W., G. F. Claassen, S. R. Hann, and M. D. Cole. 2000. The c-Myc transactivation domain is a direct modulator of apoptotic versus proliferative signals. Mol. Cell. Biol. 20:4309–4319.
   PubMed Web of Science ®Google Scholar
• Charron, J., B. A. Malynn, P. Fisher, V. Stewart, L. Jeannotte, S. P. Goff, E. J. Robertson, and F. W. Alt. 1992. Embryonic lethality in mice homozygous for a targeted disruption of the N-myc gene. Genes Dev. 6:2248–2257.
   PubMed Web of Science ®Google Scholar
• Cole, M. D., and S. B. McMahon. 1999. The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation. Oncogene 18:2916–2924.
   PubMed Web of Science ®Google Scholar
• Conzen, S. D., K. Gottlob, E. S. Kandel, P. Khanduri, A. J. Wagner, M. O'Leary, and N. Hay. 2000. Induction of cell cycle progression and acceleration of apoptosis are two separable functions of c-Myc: transrepression correlates with acceleration of apoptosis. Mol. Cell. Biol. 20:6008–6018.
   PubMedGoogle Scholar
• Dang, C. V., L. M. Resar, E. Emison, S. Kim, Q. Li, J. E. Prescott, D. Wonsey, and K. Zeller. 1999. Function of the c-Myc oncogenic transcription factor. Exp. Cell Res. 253:63–77.
   PubMed Web of Science ®Google Scholar
• Davis, A. C., M. Wims, G. D. Spotts, S. R. Hann, and A. Bradley. 1993. A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. Genes Dev. 7:671–682.
   PubMed Web of Science ®Google Scholar
• Desagher, S., A. Osen-Sand, A. Nichols, R. Eskes, S. Montessuit, S. Lauper, K. Maundrell, B. Antonsson, and J. C. Martinou. 1999. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J. Cell Biol. 144:891–901.
   PubMed Web of Science ®Google Scholar
• Dong, J., M. Naito, and T. Tsuruo. 1997. c-Myc plays a role in cellular susceptibility to death receptor- mediated and chemotherapy-induced apoptosis in human monocytic leukemia U937 cells. Oncogene 15:639–647.
   PubMedGoogle Scholar
• Eskes, R., B. Antonsson, A. Osen-Sand, S. Montessuit, C. Richter, R. Sadoul, G. Mazzei, A. Nichols, and J. C. Martinou. 1998. Bax-induced cytochrome C release from mitochondria is independent of the permeability transition pore but highly dependent on Mg2+ ions. J. Cell Biol. 143:217–224.
   PubMed Web of Science ®Google Scholar
• Evan, G., E. Harrington, A. Fanidi, H. Land, B. Amati, and M. Bennett. 1994. Integrated control of cell proliferation and cell death by the c-myc oncogene. Philos. Trans. R. Soc. Lond. B 345:269–275.
   PubMed Web of Science ®Google Scholar
• Evan, G. I., A. H. Wyllie, C. S. Gilbert, T. D. Littlewood, H. Land, M. Brooks, C. M. Waters, L. Z. Penn, and D. C. Hancock. 1992. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119–128.
   PubMed Web of Science ®Google Scholar
• Facchini, L. M., and L. Z. Penn. 1998. The molecular role of Myc in growth and transformation: recent discoveries lead to new insights. FASEB J. 12:633–651 (Review.)
   PubMed Web of Science ®Google Scholar
• Fanidi, A., E. A. Harrington, and G. I. Evan. 1992. Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 359:554–556.
   PubMed Web of Science ®Google Scholar
• Green, D. R.. 2000. Apoptotic pathways: paper wraps stone blunts scissors. Cell 102:1–4.
   PubMed Web of Science ®Google Scholar
• Green, D. R., and J. C. Reed. 1998. Mitochondria and apoptosis. Science 281:1309–1312.
   PubMed Web of Science ®Google Scholar
• Gross, A., J. Jockel, M. C. Wei, and S. J. Korsmeyer. 1998. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J. 17:3878–3885.
   PubMed Web of Science ®Google Scholar
• Gross, A., J. M. McDonnell, and S. J. Korsmeyer. 1999. BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 13:1899–1911.
   PubMed Web of Science ®Google Scholar
• Hanahan, D., and R. A. Weinberg. 2000. The hallmarks of cancer. Cell 100:57–70.
   PubMed Web of Science ®Google Scholar
• Harrington, E. A., M. R. Bennett, A. Fanidi, and G. I. Evan. 1994. c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J. 13:3286–3295.
   PubMed Web of Science ®Google Scholar
• Hueber, A. O., and G. I. Evan. 1998. Traps to catch unwary oncogenes. Trends Genet. 14:364–367.
   PubMedGoogle Scholar
• Hueber, A. O., M. Zornig, D. Lyon, T. Suda, S. Nagata, and G. I. Evan. 1997. Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis. Science 278:1305–1309.
   PubMed Web of Science ®Google Scholar
• Janicke, R. U., F. H. Lee, and A. G. Porter. 1994. Nuclear c-Myc plays an important role in the cytotoxicity of tumor necrosis factor alpha in tumor cells. Mol. Cell. Biol. 14:5661–5670.
   PubMedGoogle Scholar
• Juin, P., A. O. Hueber, T. Littlewood, and G. Evan. 1999. c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release. Genes Dev. 13:1367–1381.
   PubMed Web of Science ®Google Scholar
• Jurgensmeier, J. M., Z. Xie, Q. Deveraux, L. Ellerby, D. Bredesen, and J. C. Reed. 1998. Bax directly induces release of cytochrome c from isolated mitochondria. Proc. Natl. Acad. Sci. USA 95:4997–5002.
   PubMed Web of Science ®Google Scholar
• Kennedy, S. G., A. J. Wagner, S. D. Conzen, J. Jordan, A. Bellacosa, P. N. Tsichlis, and N. Hay. 1997. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev. 11:701–713.
   PubMed Web of Science ®Google Scholar
• Khaled, A. R., K. Kim, R. Hofmeister, K. Muegge, and S. K. Durum. 1999. Withdrawal of IL-7 induces Bax translocation from cytosol to mitochondria through a rise in intracellular pH. Proc. Natl. Acad. Sci. USA 96:14476–14481.
   PubMed Web of Science ®Google Scholar
• Klefstrom, J., I. Vastrik, E. Saksela, J. Valle, M. Eilers, and K. Alitalo. 1994. c-Myc induces cellular susceptibility to the cytotoxic action of TNF-alpha. EMBO J. 13:5442–5450.
   PubMed Web of Science ®Google Scholar
• Kroemer, G., and J. C. Reed. 2000. Mitochondrial control of cell death. Nat. Med. 6:513–519.
   PubMed Web of Science ®Google Scholar
• Li, H., S. K. Kolluri, J. Gu, M. I. Dawson, X. Cao, P. D. Hobbs, B. Lin, G. Chen, J. Lu, F. Lin, Z. Xie, J. A. Fontana, J. C. Reed, and X. Zhang. 2000. Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3. Science 289:1159–1164.
   PubMedGoogle Scholar
• Lowe, S. W., and A. W. Lin. 2000. Apoptosis in cancer. Carcinogenesis 21:485–495.
   PubMed Web of Science ®Google Scholar
• Mateyak, M. K., A. J. Obaya, S. Adachi, and J. M. Sedivy. 1997. Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination. Cell Growth Differ. 8:1039–1048.
   PubMedGoogle Scholar
• Mateyak, M. K., A. J. Obaya, and J. M. Sedivy. 1999. c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points. Mol. Cell. Biol. 19:4672–4683.
   PubMed Web of Science ®Google Scholar
• Mitchell, K. O., M. S. Ricci, T. Miyashita, D. T. Dicker, Z. Jin, J. C. Reed, and W. S. El-Deiry. 2000. Bax is a transcriptional target and mediator of c-myc-induced apoptosis. Cancer Res 60:6318–6325.
   PubMed Web of Science ®Google Scholar
• Miyashita, T., and J. C. Reed. 1995. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293–299.
   PubMed Web of Science ®Google Scholar
• Nechushtan, A., C. L. Smith, Y. T. Hsu, and R. J. Youle. 1999. Conformation of the Bax C-terminus regulates subcellular location and cell death. EMBO J. 18:2330–2341.
   PubMed Web of Science ®Google Scholar
• Nicholson, D. W.. 1999. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ. 6:1028–1042.
   PubMed Web of Science ®Google Scholar
• Oster, S. K., W. W. Marhin, C. Asker, L. M. Facchini, P. A. Dion, K. Funa, M. Post, J. M. Sedivy, and L. Z. Penn. 2000. Myc is an essential negative regulator of platelet-derived growth factor beta receptor expression. Mol. Cell. Biol. 20:6768–6778.
   PubMedGoogle Scholar
• Packham, G., C. W. Porter, and J. L. Cleveland. 1996. c-Myc induces apoptosis and cell cycle progression by separable, yet overlapping, pathways. Oncogene 13:461–469.
   PubMed Web of Science ®Google Scholar
• Pastorino, J. G., M. Tafani, R. J. Rothman, A. Marcineviciute, J. B. Hoek, and J. L. Farber. 1999. Functional consequences of the sustained or transient activation by Bax of the mitochondrial permeability transition pore. J. Biol. Chem. 274:31734–31739.
   PubMed Web of Science ®Google Scholar
• Prendergast, G. C.. 1999. Mechanisms of apoptosis by c-Myc. Oncogene 18:2967–2987.
   PubMed Web of Science ®Google Scholar
• Reed, J. C.. 1998. Bcl-2 family proteins. Oncogene 17:3225–3236.
   PubMed Web of Science ®Google Scholar
• Reed, J. C.. 1999. Dysregulation of apoptosis in cancer. J. Clin. Oncol. 17:2941–2953.
   PubMed Web of Science ®Google Scholar
• Scaffidi, C., S. Fulda, A. Srinivasan, C. Friesen, F. Li, K. J. Tomaselli, K. M. Debatin, P. H. Krammer, and M. E. Peter. 1998. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17:1675–1687.
   PubMed Web of Science ®Google Scholar
• Scaffidi, C., I. Schmitz, J. Zha, S. J. Korsmeyer, P. H. Krammer, and M. E. Peter. 1999. Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. J. Biol. Chem. 274:22532–22538.
   PubMed Web of Science ®Google Scholar
• Shi, Y., J. M. Glynn, L. J. Guilbert, T. G. Cotter, R. P. Bissonnette, and D. R. Green. 1992. Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science 257:212–214.
   PubMed Web of Science ®Google Scholar
• Shim, H., Y. S. Chun, B. C. Lewis, and C. V. Dang. 1998. A unique glucose-dependent apoptotic pathway induced by c-Myc. Proc. Natl. Acad. Sci. USA 95:1511–1516.
   PubMed Web of Science ®Google Scholar
• Stanton, B. R., A. S. Perkins, L. Tessarollo, D. A. Sassoon, and L. F. Parada. 1992. Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop. Genes Dev. 6:2235–2247.
   PubMed Web of Science ®Google Scholar
• Thompson, E. B.. 1998. The many roles of c-Myc in apoptosis. Annu. Rev. Physiol. 60:575–600.
   PubMed Web of Science ®Google Scholar
• Wagner, A. J., J. M. Kokontis, and N. Hay. 1994. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21 waf1/cip1. Genes Dev. 8:2817–2830.
   PubMed Web of Science ®Google Scholar
• Xiao, Q., G. Claassen, J. Shi, S. Adachi, J. Sedivy, and S. R. Hann. 1998. Transactivation-defective c-MycS retains the ability to regulate proliferation and apoptosis. Genes Dev. 12:3803–3808.
   PubMedGoogle Scholar
• Zhu, W., A. Cowie, G. W. Wasfy, L. Z. Penn, B. Leber, and D. W. Andrews. 1996. Bcl-2 mutants with restricted subcellular location reveal spatially distinct pathways for apoptosis in different cell types. EMBO J. 15:4130–4141.
   PubMed Web of Science ®Google Scholar